Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Notes Payables (2018)

Organogenesis Holdings (ORGO) has 2 years of Notes Payables data on record, last reported at $15.9 million in Q4 2018.

  • For Q4 2018, Notes Payables changed 0.06% year-over-year to $15.9 million; the TTM value through Dec 2018 reached $15.9 million, changed 0.06%, while the annual FY2018 figure was $15.9 million, 0.06% changed from the prior year.
  • Notes Payables reached $15.9 million in Q4 2018 per ORGO's latest filing, roughly flat from $15.9 million in the prior quarter.
  • Across five years, Notes Payables topped out at $15.9 million in Q4 2017 and bottomed at $15.9 million in Q4 2018.